VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2021 | Head and neck cancer highlights at ASCO 2021

Ari Rosenberg, MD, University of Chicago Medicine, Chicago, IL, discusses the highlights concerning head and neck cancer from the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting. Treatment with gemcitabine, cisplatin, and anti-PD-1 therapy produced promising results for the use of primary anti-PD-1 and chemotherapy to treat nasopharynx cancer. In addition, a significant pathologic response was found in resectable oral cavity cancer patients when subject to neoadjuvant immunotherapy, potentiating the use of adjuvant therapy in oral cavity cancer treatment. This interview took place at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter